San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Skylit Medical Changes Name to Clarify Medical, Appoints New CEO

San Diego medtech startup Skylit Medical has changed its name to Clarify Medical and brought in local executive James M. Sweeney as its new CEO.

Rady Children’s Hospital, Five Other Medical Centers Form Consortium

Rady Children’s Hospital-San Diego has joined five other pediatric medical centers to form the Sanford Children’s Genomic Medicine Consortium, a collaboration intended to speed the integration of genomic medicine into pediatric care and otherwise support development of new medical treatments and cures for kids.

Tease photo

Ken Song Named President/CEO of Biotech Metacrine Inc.

Metacrine Inc., a new venture launched by biotech bigwigs in San Diego last year, has appointed a new president and chief executive officer: Dr. Ken Song.

Miranda Toledano Chosen to Lead Corporate Development at Sorrento Therapeutics

San Diego’s Sorrento Therapeutics Inc., a public biopharmaceutical firm, has appointed Miranda Toledano as executive vice president of corporate development of Sorrento and president of LA Cell, Sorrento's joint venture with City of Hope.

Startup MedCrypt Raises $750,000 in Seed Funding

Encinitas-based MedCrypt, a company that offers cybersecurity technology for medical devices, has raised $750,000 in seed funding.

Explora BioLabs Setting Up Shop in San Francisco

Explora BioLabs, a growing clinical research organization headquartered in San Diego, is expanding into South San Francisco.

Tease photo

Jason M. Hannon Named President/COO at NuVasive Inc.

San Diego medical device maker NuVasive Inc. has named Jason M. Hannon president and chief operating officer.

Tease photo

Obalon Therapeutics Announces $75M IPO; Gets FDA Approval

San Diego’s Obalon Therapeutics is on a roll. After announcing a $75 million IPO on Friday, the company said this morning that it has received FDA approval of its lead product: the Obalon Balloon System.

Poseida Therapeutics Names Members of New Scientific Advisory Board

Poseida Therapeutics Inc., a local firm using gene editing to develop therapies, has announced its scientific advisory board.

Tease photo

West Health Names Zia Agha Chief Medical Officer

Dr. Zia Agha has been promoted to become chief medical officer at West Health, a clinical research, advocacy and philanthropy organization based in San Diego.

Tease photo

Synthetic Genomics Inc. May Have ‘Built’ Better Bacteria

BIOTECH: Vmax Could Be Replacement For E. Coli in Labs

Scientists at Synthetic Genomics Inc. have harnessed the fastest-growing organism on the planet to be the new workhorse of the biotech industry.

Tease photo

Co. Plans to Launch New Medical Image Management System

MEDICINE: StatRad Raises $13M, Prepares Marketing Team

A local company that only three years ago expanded from teleradiology to cloud-based medical imaging services is about to transform again.

Lpath Inc. to Merge With Texas-Based Apollo Endosurgery

San Diego drug developer Lpath Inc. is calling it quits, and merging with Austin, Texas-based Apollo Endosurgery.

Tease photo

Under The Microscope

MEDICINE: Co. Shares Its Lab Expertise to Cut Costs and Improve Care

In an industry where business models often promote outsourcing of health care services, San Diego-based blood and laboratory services company Accumen Inc. is growing quickly by doing the opposite: partnering with hospitals to make the most of their in-house blood transfusion and lab-testing operations. Since its first business deal five years ago this month, Accumen says its revenue has climbed 20 percent to 50 percent per year — unremarkable for a young company until you consider it became profitable its second year, paid cash in spring for a Michigan laboratory consulting

CardioCell LLC Retains Objective Capital Partners

San Diego biotech CardioCell LLC has retained Objective Capital Partners, an investment bank and mergers and acquisitions advisory firm, to help the company “manage growth,” the company said in a statement.